Cover Image
市場調查報告書

全球老年性黃斑部病變市場

Global Age-Related Macular Degeneration (AMD) Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 306280
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
全球老年性黃斑部病變市場 Global Age-Related Macular Degeneration (AMD) Market 2014-2018
出版日期: 2014年06月06日 內容資訊: 英文 83 Pages
簡介

老年性黃斑部病變的正確病因不明。老年性黃斑部病變分為濕型和乾型。現在濕型老年性黃斑部病變的治療方法大量存在,不過沒有乾型治療法。全球老年性黃斑部病變市場2013年∼2018將以年複合成長率6.62%擴大。

本報告提供全球老年性黃斑部病變市場現狀與未來的預測的相關調查、今後的市場規模與成長率、市場趨勢、市場成長的課題、市場機會威脅、主要供應商簡介等彙整。

第1章 摘要整理

第2章 簡稱清單

第3章 本報告的範圍

  • 市場概要
  • 產品概要
    • 產品簡介

第4章 市場調查方法

第5章 簡介

第6章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 目前老年性黃斑部病變治療的產品系列

第8章 臨床實驗平台投資組合

第9章 發病率和罹患率

  • 美國
  • 英國
  • 澳洲
  • 日本
  • 中國
  • 印度

第10章 各類型市場區隔

第11章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第12章 購買標準

第13章 推動市場成長要素

第14章 推動因素與其影響

第15章 市場課題

第16章 推動因素與課題的影響

第17章 市場趨勢

第18章 趨勢與其影響

第19章 供應商環境

  • 競爭模式
    • 最新資訊
    • 合併、收購
  • 2013年的市場分析
  • 其他值得注意的供應商
  • 預計將開拓老年性黃斑部病變市場的未來供應商

第20章 本系列的報告介紹

圖表

目錄
Product Code: IRTNTR3530

About AMD

AMD is defined as the deterioration of the eye's macula. The macula is a small area in the retina that is responsible for central vision. The exact etiology of AMD is unknown. There are two types of macular degeneration: wet and dry. Wet AMD occurs when tiny abnormal blood vessels begin growing behind the retina toward the macula. Dry AMD occurs when small, yellowish deposits called drusen begin accumulating beneath the macula. While a number of treatments are available for wet AMD, there is no treatment available at the moment for dry AMD.

TechNavio's analysts forecast the Global AMD market will grow at a CAGR of 6.62 percent over the period 2013-2018.

Covered in this Report

The Global AMD market can be divided into two segments: Dry AMD and Wet AMD. This report covers the present scenario and the growth prospects of the Global AMD market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of AMD.

TechNavio's report, the Global AMD Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global AMD market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.

Other Prominent Vendors

  • Acucela Inc.
  • Advanced Cell Technology Inc.
  • Alexion Pharmaceuticals Inc.
  • Alimera Sciences Inc.
  • Allergen Inc.
  • Allergo Opthalmics LLC
  • Avalanche Biotechnologies Inc.
  • Gilead Sciences Inc.
  • GlaxoSmithKline plc
  • Icon Bioscience Inc.
  • Intellect Neurosciences Inc.
  • Lpath Inc.
  • Neurotech Pharmaceuticals Inc.
  • Opthotech Corp.
  • OSI Pharmaceuticals Inc.
  • Oxigene Inc.
  • PanOptica Inc.
  • Pfizer Inc.
  • Santen Pharmaceutical Co. Ltd.
  • StemCells Inc.
  • Synthetic Biologics Inc.
  • Thrombogenics NV
  • Valeant Pharmaceuticals International Inc.

Key Market Driver

  • Increase in Aging Population.

For a full, detailed list, view our report.

Key Market Challenge

  • Increase in Off Label Use.

For a full, detailed list, view our report.

Key Market Trend

  • Increase in Awareness of AMD.

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings
    • 03.2.1. Product Profiles

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Product Portfolio of Current AMD Therapies 08. Clinical Pipeline Portfolio

09. Rate of Incidence and Prevalence

  • 09.1.1. US
  • 09.1.2. UK
  • 09.1.3. Australia
  • 09.1.4. Japan
  • 09.1.5. China
  • 09.1.6. India

10. Market Segmentation by Types

11. Geographical Segmentation

  • 11.1. AMD Market in the Americas
    • 11.1.1. Market Size and Forecast
  • 11.2. AMD Market in the EMEA Region
    • 11.2.1. Market Size and Forecast
  • 11.3. AMD Market in the APAC Region
    • 11.3.1. Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Analysis 2013
  • 19.3. Other Prominent Vendors
  • 19.4. Future Vendors Expected To Tap AMD Market

20. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global AMD Market 2013-2018 (US$ billion)
  • Exhibit 3: Global AMD Market Segmentation by Types
  • Exhibit 4: Global AMD Market by Geographical Segmentation 2013
  • Exhibit 5: AMD Market in the Americas 2013-2018 (US$ billion)
  • Exhibit 6: AMD Market in the EMEA Region 2013-2018 (US$ billion)
  • Exhibit 7: Global AMD Market by Major Product Share 2013
Back to Top